Hypermethylation and loss of heterozygosity of tumor suppressor genes on chromosome 3p in cervical cancer

Cancer Letters

Volumn 255, Issue 1, 2007, Pages 26-33

  Choi, Chel Hun ^a   Lee, Kyung Mee ^a   Choi, Jung Joo ^a   Kim, Tae Joong ^a   Kim, Woo Young ^a   Lee, Jeong Won ^a   Lee, Sun Joo ^b   Lee, Je Ho ^a   Bae, Duk Soo ^a   Kim, Byoung Gie ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Konkuk University Hospital   (South Korea)

Author keywords

Cervical squamous cell carcinoma; Loss of heterozygosity; Promoter hypermethylation; Tumor suppressor genes

Indexed keywords

DNA; FRAGILE HISTIDINE TRIAD PROTEIN; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; RETINOIC ACID RECEPTOR BETA; VON HIPPEL LINDAU PROTEIN;

ADULT; AGED; ARTICLE; CHROMOSOME 3P; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; DNA METHYLATION; FEMALE; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; METHYLATION SPECIFIC POLYMERASE CHAIN REACTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CANCER;

ACID ANHYDRIDE HYDROLASES; AGED; CARCINOMA, SQUAMOUS CELL; CHROMOSOMES, HUMAN, PAIR 3; DNA; DNA METHYLATION; DNA PRIMERS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; LYMPHATIC METASTASIS; METHYLATION; MIDDLE AGED; NEOPLASM PROTEINS; UTERINE CERVICAL NEOPLASMS;

EID: 34547670512     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.03.015     Document Type: Article

References (31)

1. Pisani P., Bray F., and Parkin D.M. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int. J. Cancer 97 (2002) 72-81
2. Ylitalo N., Sorensen P., Josefsson A.M., Magnusson P.K., Andersen P.K., Ponten J., et al. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet 355 (2000) 2194-2198
3. Chan M.W., Chan L.W., Tang N.L., Tong J.H., Lo K.W., Lee T.L., et al. Hypermethylation of multiple genes in tumor tissues and voided urine in urinary bladder cancer patients. Clin. Cancer Res. 8 (2002) 464-470
4. Esteller M. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 21 (2002) 5427-5440
5. Jin Z., Tamura G., Tsuchiya T., Sakata K., Kashiwaba M., Osakabe M., et al. Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers. Br. J. Cancer 85 (2001) 69-73
6. Soria J.C., Lee H.Y., Lee J.I., Wang L., Issa J.P., Kemp B.L., et al. Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation. Clin. Cancer Res. 8 (2002) 1178-1184
7. Toyota M., Ahuja N., Ohe-Toyota M., Herman J.G., Baylin S.B., and Issa J.P. CpG island methylator phenotype in colorectal cancer. Proc. Natl. Acad. Sci. USA 96 (1999) 8681-8686
8. Huebner K. Tumor suppressors on 3p: a neoclassic quartet. Proc. Natl. Acad. Sci. USA 98 (2001) 14763-14765
9. Lerman M.I., and Minna J.D. The 630 kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. Cancer Res. 60 (2000) 6116-6133
10. Dammann R., Li C., Yoon J.H., Chin P.L., Bates S., and Pfeifer G.P. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat. Genet. 25 (2000) 315-319
11. de The H., Vivanco-Ruiz M.M., Tiollais P., Stunnenberg H., and Dejean A. Identification of a retinoic acid responsive element in the retinoic acid receptor beta gene. Nature 343 (1990) 177-180
12. Latif F., Tory K., Gnarra J., Yao M., Duh F.M., Orcutt M.L., et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260 (1993) 1317-1320
13. Ohta M., Inoue H., Cotticelli M.G., Kastury K., Baffa R., Palazzo J., et al. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84 (1996) 587-597
14. Mori M., Shiraishi T., Tanaka S., Yamagata M., Mafune K., Tanaka Y., et al. Lack of DMBT1 expression in oesophageal, gastric and colon cancers. Br. J. Cancer 79 (1999) 211-213
15. Herman J.G., Graff J.R., Myohanen S., Nelkin B.D., and Baylin S.B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA 93 (1996) 9821-9826
16. Cote S., Sinnett D., and Momparler R.L. Demethylation by 5-aza-2′-deoxycytidine of specific 5-methylcytosine sites in the promoter region of the retinoic acid receptor beta gene in human colon carcinoma cells. Anticancer Drugs 9 (1998) 743-750
17. Lo K.W., Kwong J., Hui A.B., Chan S.Y., To K.F., Chan A.S., et al. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. Cancer Res. 61 (2001) 3877-3881
18. Zochbauer-Muller S., Fong K.M., Maitra A., Lam S., Geradts J., Ashfaq R., et al. 5′ CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer. Cancer Res. 61 (2001) 3581-3585
19. Feng Q., Balasubramanian A., Hawes S.E., Toure P., Sow P.S., Dem A., et al. Detection of hypermethylated genes in women with and without cervical neoplasia. J. Natl. Cancer Inst. 97 (2005) 273-282
20. Ivanova T., Petrenko A., Gritsko T., Vinokourova S., Eshilev E., Kobzeva V., et al. Methylation and silencing of the retinoic acid receptor-beta 2 gene in cervical cancer. BMC Cancer 2 (2002) 4
21. Narayan G., Arias-Pulido H., Koul S., Vargas H., Zhang F.F., Villella J., et al. Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome. Mol. Cancer 2 (2003) 24
22. Zambrano P., Segura-Pacheco B., Perez-Cardenas E., Cetina L., Revilla-Vazquez A., Taja-Chayeb L., et al. A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes. BMC Cancer 5 (2005) 44
23. Dong S.M., Kim H.S., Rha S.H., and Sidransky D. Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix. Clin. Cancer Res. 7 (2001) 1982-1986
24. Kang S., Kim J.W., Kang G.H., Park N.H., Song Y.S., Kang S.B., et al. Polymorphism in folate- and methionine-metabolizing enzyme and aberrant CpG island hypermethylation in uterine cervical cancer. Gynecol. Oncol. 96 (2005) 173-180
25. Virmani A.K., Muller C., Rathi A., Zoechbauer-Mueller S., Mathis M., and Gazdar A.F. Aberrant methylation during cervical carcinogenesis. Clin. Cancer Res. 7 (2001) 584-589
26. Kuroki T., Trapasso F., Yendamuri S., Matsuyama A., Alder H., Mori M., et al. Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma. Cancer Res. 63 (2003) 3724-3728
27. Knudson Jr. A.G. Hereditary cancer, oncogenes, and antioncogenes. Cancer Res. 45 (1985) 1437-1443
28. Yu M.Y., Tong J.H., Chan P.K., Lee T.L., Chan M.W., Chan A.W., et al. Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers. Int. J. Cancer 105 (2003) 204-209
29. Khan M.A., Jenkins G.R., Tolleson W.H., Creek K.E., and Pirisi L. Retinoic acid inhibition of human papillomavirus type 16-mediated transformation of human keratinocytes. Cancer Res. 53 (1993) 905-909
30. Meyskens Jr. F.L., Surwit E., Moon T.E., Childers J.M., Davis J.R., Dorr R.T., et al. Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial. J. Natl. Cancer Inst. 86 (1994) 539-543
31. Zochbauer-Muller S., Fong K.M., Virmani A.K., Geradts J., Gazdar A.F., and Minna J.D. Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res. 61 (2001) 249-255